Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 473

1.

Weight loss predicts mortality after recurrent oral cavity and oropharyngeal carcinomas.

Nguyen TV, Yueh B.

Cancer. 2002 Aug 1;95(3):553-62.

PMID:
12209747
[PubMed - indexed for MEDLINE]
Free Article
2.

Prognostic staging system for recurrent, persistent, and second primary cancers of the oral cavity and oropharynx.

Yueh B, Feinstein AR, Weaver EM, Sasaki CT, Concato J.

Arch Otolaryngol Head Neck Surg. 1998 Sep;124(9):975-81.

PMID:
9738805
[PubMed - indexed for MEDLINE]
3.

Development of a new staging system for recurrent oral cavity and oropharyngeal squamous cell carcinoma.

Lacy PD, Spitznagel EL Jr, Piccirillo JF.

Cancer. 1999 Oct 15;86(8):1387-95.

PMID:
10526264
[PubMed - indexed for MEDLINE]
4.

Salvage treatment for recurrent squamous cell carcinoma of the oral cavity.

Schwartz GJ, Mehta RH, Wenig BL, Shaligram C, Portugal LG.

Head Neck. 2000 Jan;22(1):34-41.

PMID:
10585603
[PubMed - indexed for MEDLINE]
5.

Perioperative complications, comorbidities, and survival in oral or oropharyngeal cancer.

de Cássia Braga Ribeiro K, Kowalski LP, Latorre Mdo R.

Arch Otolaryngol Head Neck Surg. 2003 Feb;129(2):219-28.

PMID:
12578453
[PubMed - indexed for MEDLINE]
6.

Development of a new staging system for patients with recurrent laryngeal squamous cell carcinoma.

Lacy PD, Piccirillo JF.

Cancer. 1998 Sep 1;83(5):910-7.

PMID:
9731894
[PubMed - indexed for MEDLINE]
7.

The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.

Layland MK, Sessions DG, Lenox J.

Laryngoscope. 2005 Apr;115(4):629-39.

PMID:
15805872
[PubMed - indexed for MEDLINE]
8.

Clinical-severity staging system for oropharyngeal cancer: five-year survival rates.

Pugliano FA, Piccirillo JF, Zequeira MR, Emami B, Perez CA, Simpson JR, Fredrickson JM.

Arch Otolaryngol Head Neck Surg. 1997 Oct;123(10):1118-24.

PMID:
9339990
[PubMed - indexed for MEDLINE]
9.

Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997.

Grabenbauer GG, Rödel C, Brunner T, Schulze-Mosgau S, Strnad V, Müller RG, Iro H, Sauer R.

Strahlenther Onkol. 2001 Jul;177(7):338-44.

PMID:
11505619
[PubMed - indexed for MEDLINE]
10.

Biological markers and prognosis in recurrent oral cancer after salvage surgery.

Agra IM, Carvalho AL, Pinto CA, Martins EP, Filho JG, Soares FA, Kowalski LP.

Arch Otolaryngol Head Neck Surg. 2008 Jul;134(7):743-9. doi: 10.1001/archotol.134.7.743.

PMID:
18645125
[PubMed - indexed for MEDLINE]
11.

Clinical-severity staging system for oral cavity cancer: five-year survival rates.

Pugliano FA, Piccirillo JF, Zequeira MR, Fredrickson JM, Perez CA, Simpson JR.

Otolaryngol Head Neck Surg. 1999 Jan;120(1):38-45.

PMID:
9914547
[PubMed - indexed for MEDLINE]
12.

A comparison between TNM and TANIS stage grouping for predicting prognosis of oral and oropharyngeal cancer.

Carinci F, Pelucchi S, Farina A, Calearo C.

J Oral Maxillofac Surg. 1998 Jul;56(7):832-6; discussion 836-7.

PMID:
9663573
[PubMed - indexed for MEDLINE]
13.

The prognostic impact of metastatic pattern of lymph nodes in patients with oral and oropharyngeal squamous cell carcinomas.

Wenzel S, Sagowski C, Kehrl W, Metternich FU.

Eur Arch Otorhinolaryngol. 2004 May;261(5):270-5. Epub 2003 Sep 18.

PMID:
14504863
[PubMed - indexed for MEDLINE]
14.

Is the new TNM (1997) the best system for predicting prognosis?

Carinci F, Farina A, Longhini L, Urso RG, Pelucchi S, Calearo C.

Int J Oral Maxillofac Surg. 1999 Jun;28(3):203-5.

PMID:
10355943
[PubMed - indexed for MEDLINE]
15.

A proposed staging system for rectal carcinoid tumors based on an analysis of 4701 patients.

Landry CS, Brock G, Scoggins CR, McMasters KM, Martin RC 2nd.

Surgery. 2008 Sep;144(3):460-6. doi: 10.1016/j.surg.2008.05.005. Epub 2008 Jul 25.

PMID:
18707046
[PubMed - indexed for MEDLINE]
16.

Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer.

Agra IM, Carvalho AL, Ulbrich FS, de Campos OD, Martins EP, Magrin J, Kowalski LP.

Head Neck. 2006 Feb;28(2):107-13.

PMID:
16388526
[PubMed - indexed for MEDLINE]
17.

A matched control study of treatment outcome in young patients with squamous cell carcinoma of the head and neck.

Verschuur HP, Irish JC, O'Sullivan B, Goh C, Gullane PJ, Pintilie M.

Laryngoscope. 1999 Feb;109(2 Pt 1):249-58.

PMID:
10890775
[PubMed - indexed for MEDLINE]
18.

Radiation therapy for early-stage carcinoma of the oropharynx.

Selek U, Garden AS, Morrison WH, El-Naggar AK, Rosenthal DI, Ang KK.

Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):743-51.

PMID:
15183477
[PubMed - indexed for MEDLINE]
19.

Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.

Haughey BH, Sinha P.

Laryngoscope. 2012 Sep;122 Suppl 2:S13-33. doi: 10.1002/lary.23493.

PMID:
22926949
[PubMed - indexed for MEDLINE]
20.

Analysis of prognostic factors in patients with oropharyngeal squamous cell carcinoma treated with radiotherapy alone or in combination with systemic chemotherapy.

Pedruzzi PA, Kowalski LP, Nishimoto IN, Oliveira BV, Tironi F, Ramos GH.

Arch Otolaryngol Head Neck Surg. 2008 Nov;134(11):1196-204. doi: 10.1001/archotol.134.11.1196.

PMID:
19015451
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk